SARS-CoV-2 vaccination in haemodialysis patients: Insides from a prospective study comparing mRNA and viral vector vaccines
Saved in:
Main Authors: | Louise Füessl (Author), Ulf Schönermarck (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients
by: Sandra Hasmann, et al.
Published: (2021) -
SARS-CoV-2 mRNA vaccination and subsequent herpes zoster: Possible immune reconstitution by mRNA vaccination
by: Mitsuhito Ota, MD, PhD
Published: (2022) -
B-Cell Responses to Sars-Cov-2 mRNA Vaccines
by: Lela Kardava, et al.
Published: (2022) -
Effectiveness of mRNA, protein subunit vaccine and viral vectors vaccines against SARS-CoV-2 in people over 18 years old: a systematic review
by: Cristian Sandoval, et al.
Published: (2023) -
Pilomatricoma growing at the SARS-CoV-2 mRNA vaccination site
by: Merve Hatun Erkayman, et al.
Published: (2023)